雌孕激素反向添加法在GnRHa治疗子宫内膜异位症中的疗效及安全性研究

吴粉兰; 丁小梅

doi:10.13898/j.cnki.issn.1000-2200.2018.12.022

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

雌孕激素反向添加法在GnRHa治疗子宫内膜异位症中的疗效及安全性研究

吴粉兰 , 丁小梅

文章导航 > 蚌埠医学院学报 > 2018, 43 > 12: (1616-1619)

引用本文:

Citation:

雌孕激素反向添加法在GnRHa治疗子宫内膜异位症中的疗效及安全性研究

苏州明基医院妇产科, 江苏苏州 215000

作者简介: 吴粉兰(1974-),女,副主任医师.

中图分类号: R711.71

Efficacy and safety of the GnRHa combined with hormone in the treatment of endometriosis

Department of Obstetrics and Gynecology, Mingji Hospital, Suzhou Jiangsu 215000, China
CLC number: R711.71

摘要: 目的：探讨在促性腺激素释放激素激动剂（GnRHa）治疗方案中联合运用雌孕激素反向添加对子宫内膜异位症病人的治疗效果，并分析临床安全性。方法：选择子宫内膜异位症病人124例，按照完全随机分组原则分为对照组和观察组。2组病人均首先接受保守性手术治疗，其后，对照组病人接受皮下注射诺雷得治疗，观察组病人接受皮下注射诺雷得联合口服地屈孕酮和戊酸雌二醇治疗。分别评估病人治疗前后盆腔痛、性交痛和痛经的疼痛程度；测定不同时间点病人血清雌激素（E₂）、黄体生成素（LH）和卵泡刺激素（FSH）水平；评估治疗后病人性欲减退、失眠、骨痛等绝经症状的发生率。结果：治疗前，2组病人盆腔痛、性交痛、痛经痛得分以及E₂和LH、FSH表达水平差异均无统计学意义（P>0.05），治疗后，2组病人的盆腔痛和性交痛得分显著低于治疗前，疼痛感均明显降低（P<0.01），同时2组病人的LH、FSH表达水平显著低于治疗前（P<0.01）；此外，治疗后2组病人在失眠、盗汗、性欲减退这三种绝经症状的发生率上差异无统计学意义（P>0.05），但在潮热、情绪波动和骨痛3种绝经症状的发生率上观察组病人低于对照组病人（P>0.05）。结论：雌孕激素反向添加法在GnRHa治疗子宫内膜异位症中可以使维持雌激素处于正常水平，改善绝经症状，缓解疼痛，值得临床推广。
- 子宫内膜异位症 /
- 反向添加疗法 /
- 雌激素 /
- 绝经
Abstract: Objective:To investigate the effects and safety of the GnRHa combined with hormone in the treatment of endometriosis.Methods:One hundred and twenty-four patients with endometriosis were randomly divided into the control group and experimental group.Two groups were treated with conservative surgery,then the control group were additionally treated with Zoladex by subcutaneous injection,and the experimental group were additionally treated with Zoladex by subcutaneous injection combined with flexion progesterone and estradiol valerate by oral.The pain degrees of the pelvic pain,dyspareunia and dysmenorrhea were evaluated before and after treatment.The serum levels of estrogen(E₂),LH and follicle stimulating hormone(FSH) at different time-points were measured.The incidence rate of insomnia,libido and bone pain in two groups were evaluated after treatment.Results:Before treatment,the differences of the scores of pelvic pain,dyspareunia and dysmenorrhea,and serum levels of E₂,LH and FSH between two groups were not statistically significant(P>0.05).After treatment,the scores of pelvic pain and dyspareunia,and its pain degree in two groups significantly decreased compared before treatment(P<0.01),and the serum levels of LH and FSH were significantly lower than those before treatment(P<0.01).After treatment,the differences of the incidence rates of the insomnia,night sweat,sexual desire drop between two groups were not statistically significant(P>0.05),but the incidence rates of hectic fever,mood swing and bone pain in experimental group were significantly lower than those in control group(P<0.05).Conclusions:The GnRHa combined with hormone in the treatment of endometriosis can maintain the normal level of estrogen,improve menopausal symptoms and relieve pain,and which is worthy of clinical promotion.
- endometriosis /
- hormone therapy /
- estrogen /
- menopause

[1]	CULLEY L,LAW C,HUDSON N,et al.A qualitative study of the impact of endometriosis on male partners[J].Hum Reprod,2017,32(8):1667.
[2]	ZONDERVAN KT,RAHMIOGLU N,MORRIS AP,et al.Beyond endometriosis GWAS:from genomics to phenomics to the patient[J].Semin Reprod Med,2016,34(4):242.
[3]	AREDO JV,HEYRANA KJ,KARP BI,et al.Relating chronic pelvic pain and endometriosis to signs of sensitization and myofascial pain and dysfunction[J].Semin Reprod Med,2017,35(1):88.
[4]	STILLEY JAW,BIRT JA,SHARPE-TIMMS KL.Cellular and molecular basis for endometriosis-associated infertility[J].Cell Tissue Res,2012,349(3):849.
[5]	仝佳丽,郎景和,冷金花,等.重度子宫内膜异位症腹腔镜术后联合GnRHa治疗效果及反加疗法的影响[J].现代妇产科进展,2008,17(11):839.
[6]	张团英,符爱珍,张凤兰,等.保守性手术后促性腺激素释放激素激动剂联合反加疗法治疗中重度子宫内膜异位症的疗效观察[J].中国妇幼保健,2007,22(33):4669.
[7]	张春燕,耿爱芝.促性腺激素释放激素激动剂联合克龄蒙在子宫内膜异位症保守性手术后的应用[J].广东医学,2013,34(3):454.
[8]	牛子儒,岳晓静,孔群钰,等.反加疗法在促性腺激素释放激素激动剂治疗内异症中减缓骨量流失的荟萃分析[J].中华妇产科杂志,2013,48(5):338.
[9]	范宝光,任琛琛.GnRHa联合反加疗法用于腹腔镜术后子宫内膜异位症的临床观察[J].国际妇产科学杂志,2013,40(1):75.
[10]	甄小文,阙贵珍,冯满欢,等.GnRHa联合反加疗法治疗保守性手术后中重度子宫内膜异位症的临床分析[J].中国现代医药杂志,2011,13(4):61.
[11]	罗静,谭广萍.盆腔子宫内膜异位症保留生育功能手术后促性腺激素释放激素联合反加疗法的疗效观察[J].中国医师进修杂志,2010,33(18):45.

[1]	丁坤琼 , 毛世华 , 谈宗国 . 坤泰胶囊与雌激素替代疗法联合治疗围绝经期综合征的疗效分析. 蚌埠医学院学报, 2018, 43(9): 1163-1165. doi: 10.13898/j.cnki.issn.1000-2200.2018.09.013
[2]	李群 . 改进养膜方联合雌激素对肾虚血瘀型薄型子宫内膜病人子宫内膜容受性和子宫血流动力学的影响. 蚌埠医学院学报, 2017, 42(11): 1517-1521. doi: 10.13898/j.cnki.issn.1000-2200.2017.11.025
[3]	叶志恒 , 储小宏 , 贾丽 , 赵广碧 , 吴帮庆 . 绝经后糖耐量减低者性激素的变化. 蚌埠医学院学报, 2009, 34(1): 59-60.
[4]	倪帼华 , 周有芬 , 殷梅英 . 超声、宫腔镜、病理检查对绝经后子宫内膜病变的诊断价值. 蚌埠医学院学报, 2004, 29(1): 60-61.
[5]	陈鹃 , 陈雄 . 腹腔镜辅助下阴道顶端悬吊术治疗绝经后子宫脱垂的疗效. 蚌埠医学院学报, 2013, 37(6): 707-709.
[6]	丁惠民 , 陈晖 , 颜世昌 , 彭俊洋 , 魏建军 , 张莉 . 绝经后女性骨关节炎血清性激素水平与血清CRP、ESR的相关性. 蚌埠医学院学报, 2016, 41(12): 1597-1599. doi: 10.13898/j.cnki.issn.1000-2200.2016.12.018
[7]	姜迎春 . 宫腔镜下诊治绝经后子宫出血60例. 蚌埠医学院学报, 2014, 39(7): 945-946.
[8]	李芳 . 尼尔雌醇用于绝经后妇女取宫内节育器106例分析. 蚌埠医学院学报, 2012, 36(7): 839-840.
[9]	叶爱华 . 米索前列醇在绝经后妇女取宫内避孕器术中的应用. 蚌埠医学院学报, 2007, 32(4): 464-465.
[10]	茅惠群 . 腹壁子宫内膜异位症9例临床治疗体会. 蚌埠医学院学报, 2009, 34(12): 1121-1122.
[11]	李玉芝 , 李燕华 , 孙蕊 . 子宫内膜异位症术后辅助甲羟孕酮治疗临床观察. 蚌埠医学院学报, 2004, 29(5): 391-392.
[12]	申庆文 , 凌斌 . KiSS-1及MMP-9与子宫内膜异位症关系的研究进展. 蚌埠医学院学报, 2009, 34(4): 359-361.
[13]	乔娟 , 温娜 . 子宫内膜异位症患者腹腔液及血清中IL-12的水平测定. 蚌埠医学院学报, 2010, 35(6): 591-592.
[14]	刘敏 . 手术联合药物治疗子宫内膜异位症痛经的疗效观察. 蚌埠医学院学报, 2013, 37(3): 283-285.
[15]	赵磐琳 , 庞春元 . 子宫内膜异位症不孕病人腹腔镜术后妊娠的影响因素分析. 蚌埠医学院学报, 2017, 42(6): 781-783. doi: 10.13898/j.cnki.issn.1000-2200.2017.06.027
[16]	彭华 , 张燕 , 朱翠婷 , 许韶荣 . 孕三烯酮对子宫内膜异位症腹腔镜术后氧化应激状态的影响. 蚌埠医学院学报, 2012, 36(6): 663-665.
[17]	阳桂芬 , 邓文 . 子宫内膜异位症病人炎症因子和凝血因子的水平变化及临床意义. 蚌埠医学院学报, 2022, 47(2): 212-214, 218. doi: 10.13898/j.cnki.issn.1000-2200.2022.02.019
[18]	翟敬芳 , 丛林 , 欧玉荣 . 血管内皮生长因子及其激酶插入区受体在卵巢子宫内膜异位症中的表达及意义. 蚌埠医学院学报, 2010, 35(4): 343-346.
[19]	王习习 , 李金芝 . 影响围绝经期综合征发生的生物-心理-社会因素的研究进展. 蚌埠医学院学报, 2016, 41(3): 419-420. doi: 10.13898/j.cnki.issn.1000-2200.2016.03.046
[20]	王晗 , 高薇炜 . 子宫颈癌100例临床病理特征分析. 蚌埠医学院学报, 2011, 36(11): 1223-1224.

点击查看大图

计量

文章访问数: 5055
HTML全文浏览量: 927
PDF下载量: 10
被引次数: 0

雌孕激素反向添加法在GnRHa治疗子宫内膜异位症中的疗效及安全性研究

作者简介: 吴粉兰(1974-),女,副主任医师.

苏州明基医院妇产科, 江苏苏州 215000

收稿日期: 2016-03-30
录用日期: 2018-11-30

关键词:

摘要: 目的：探讨在促性腺激素释放激素激动剂（GnRHa）治疗方案中联合运用雌孕激素反向添加对子宫内膜异位症病人的治疗效果，并分析临床安全性。方法：选择子宫内膜异位症病人124例，按照完全随机分组原则分为对照组和观察组。2组病人均首先接受保守性手术治疗，其后，对照组病人接受皮下注射诺雷得治疗，观察组病人接受皮下注射诺雷得联合口服地屈孕酮和戊酸雌二醇治疗。分别评估病人治疗前后盆腔痛、性交痛和痛经的疼痛程度；测定不同时间点病人血清雌激素（E₂）、黄体生成素（LH）和卵泡刺激素（FSH）水平；评估治疗后病人性欲减退、失眠、骨痛等绝经症状的发生率。结果：治疗前，2组病人盆腔痛、性交痛、痛经痛得分以及E₂和LH、FSH表达水平差异均无统计学意义（P>0.05），治疗后，2组病人的盆腔痛和性交痛得分显著低于治疗前，疼痛感均明显降低（P<0.01），同时2组病人的LH、FSH表达水平显著低于治疗前（P<0.01）；此外，治疗后2组病人在失眠、盗汗、性欲减退这三种绝经症状的发生率上差异无统计学意义（P>0.05），但在潮热、情绪波动和骨痛3种绝经症状的发生率上观察组病人低于对照组病人（P>0.05）。结论：雌孕激素反向添加法在GnRHa治疗子宫内膜异位症中可以使维持雌激素处于正常水平，改善绝经症状，缓解疼痛，值得临床推广。

English Abstract

Efficacy and safety of the GnRHa combined with hormone in the treatment of endometriosis

Department of Obstetrics and Gynecology, Mingji Hospital, Suzhou Jiangsu 215000, China

Received Date: 2016-03-30
Accepted Date: 2018-11-30

Abstract: Objective:To investigate the effects and safety of the GnRHa combined with hormone in the treatment of endometriosis.Methods:One hundred and twenty-four patients with endometriosis were randomly divided into the control group and experimental group.Two groups were treated with conservative surgery,then the control group were additionally treated with Zoladex by subcutaneous injection,and the experimental group were additionally treated with Zoladex by subcutaneous injection combined with flexion progesterone and estradiol valerate by oral.The pain degrees of the pelvic pain,dyspareunia and dysmenorrhea were evaluated before and after treatment.The serum levels of estrogen(E₂),LH and follicle stimulating hormone(FSH) at different time-points were measured.The incidence rate of insomnia,libido and bone pain in two groups were evaluated after treatment.Results:Before treatment,the differences of the scores of pelvic pain,dyspareunia and dysmenorrhea,and serum levels of E₂,LH and FSH between two groups were not statistically significant(P>0.05).After treatment,the scores of pelvic pain and dyspareunia,and its pain degree in two groups significantly decreased compared before treatment(P<0.01),and the serum levels of LH and FSH were significantly lower than those before treatment(P<0.01).After treatment,the differences of the incidence rates of the insomnia,night sweat,sexual desire drop between two groups were not statistically significant(P>0.05),but the incidence rates of hectic fever,mood swing and bone pain in experimental group were significantly lower than those in control group(P<0.05).Conclusions:The GnRHa combined with hormone in the treatment of endometriosis can maintain the normal level of estrogen,improve menopausal symptoms and relieve pain,and which is worthy of clinical promotion.